Shares of Cabot Co. (NYSE:CBT – Get Free Report) have been assigned a consensus rating of “Hold” from the five research firms that are currently covering the company, Marketbeat Ratings reports. Three analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average 1-year target price among brokers that have updated their coverage on the stock in the last year is $90.17.
A number of equities research analysts recently commented on the stock. Deutsche Bank Aktiengesellschaft downgraded shares of Cabot from a “buy” rating to a “hold” rating and raised their price objective for the company from $88.00 to $95.00 in a research report on Thursday, April 18th. UBS Group downgraded shares of Cabot from a “buy” rating to a “neutral” rating and reduced their price objective for the company from $90.00 to $87.00 in a research report on Monday, January 8th. StockNews.com downgraded shares of Cabot from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, February 14th. Finally, Mizuho assumed coverage on shares of Cabot in a research report on Wednesday, March 27th. They issued a “buy” rating and a $104.00 price objective for the company.
View Our Latest Research Report on CBT
Insider Activity
Institutional Inflows and Outflows
Several institutional investors have recently modified their holdings of the stock. Ronald Blue Trust Inc. lifted its stake in Cabot by 460.7% in the 3rd quarter. Ronald Blue Trust Inc. now owns 1,895 shares of the specialty chemicals company’s stock valued at $127,000 after buying an additional 1,557 shares in the last quarter. SG Americas Securities LLC lifted its stake in Cabot by 416.6% in the 3rd quarter. SG Americas Securities LLC now owns 21,535 shares of the specialty chemicals company’s stock valued at $1,492,000 after buying an additional 17,366 shares in the last quarter. Raymond James & Associates lifted its stake in Cabot by 5.0% in the 3rd quarter. Raymond James & Associates now owns 41,878 shares of the specialty chemicals company’s stock valued at $2,901,000 after buying an additional 1,986 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank lifted its stake in Cabot by 18.8% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 11,476 shares of the specialty chemicals company’s stock valued at $795,000 after buying an additional 1,819 shares in the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. lifted its stake in Cabot by 17.5% in the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 175,336 shares of the specialty chemicals company’s stock valued at $12,146,000 after buying an additional 26,052 shares in the last quarter. 93.18% of the stock is currently owned by institutional investors and hedge funds.
Cabot Stock Performance
Shares of CBT stock opened at $93.42 on Thursday. The stock’s 50-day moving average is $88.80 and its two-hundred day moving average is $80.17. The firm has a market cap of $5.18 billion, a price-to-earnings ratio of 12.13, a PEG ratio of 0.98 and a beta of 1.28. Cabot has a 1 year low of $63.73 and a 1 year high of $98.34. The company has a debt-to-equity ratio of 0.74, a quick ratio of 1.30 and a current ratio of 2.04.
Cabot (NYSE:CBT – Get Free Report) last issued its quarterly earnings data on Monday, February 5th. The specialty chemicals company reported $1.56 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.49 by $0.07. Cabot had a return on equity of 25.52% and a net margin of 11.24%. The company had revenue of $958.00 million for the quarter, compared to analyst estimates of $927.28 million. Analysts predict that Cabot will post 6.58 earnings per share for the current year.
Cabot Company Profile
Cabot Corporation operates as a specialty chemicals and performance materials company. The company operates through two segments, Reinforcement Materials and Performance Chemicals. It offers reinforcing carbons that are used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites solutions.
Further Reading
- Five stocks we like better than Cabot
- Most Volatile Stocks, What Investors Need to Know
- High-Yield Texas Instruments Could Hit New Highs Soon
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Pagaya Technologies: An AI Fintech That Insiders Are Buying
- What is the Australian Securities Exchange (ASX)
- Higher Oil Prices Could Give NextEra’s Stock Earnings a Boost
Receive News & Ratings for Cabot Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cabot and related companies with MarketBeat.com's FREE daily email newsletter.